Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 43 | +4 |
| Shares | 17.8M | 19.3K | 31.3M | +13.6M (+76.2%) |
| Value | $29.7M | $32.3K | $56.4M | +$26.7M (+89.9%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 2,000,000 | $3.58M | 0.07% |
| Nantahala Capital Management, LLC | 1,750,000 | $3.13M | 0.31% |
| Stonepine Capital Management, LLC | 1,462,296 | $2.62M | 2.08% |
| Altium Capital Management LP | 1,212,882 | $2.17M | 0.97% |
| Velan Capital Investment Management LP | 650,000 | $1.16M | 0.63% |
| Monashee Investment Management LLC | 500,000 | $895.0K | 0.11% |
| Bank of Montreal | 273,100 | $786.5K | 0.00% |
| ADAR1 Capital Management, LLC | 202,460 | $362.4K | 0.10% |
| Cetera Investment Advisers | 17,427 | $31.2K | 0.00% |
| XTX Topco Ltd | 13,403 | $24.0K | 0.00% |
| UBS Group AG | 2,618 | $4.69K | 0.00% |
Sold out (7)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| VR Adviser, LLC | 925,048 | $1.54M |
| Group One Trading, L.P. | 20,762 | $34.7K |
| BIT Capital GmbH | 20,000 | $33.4K |
| Virtu Financial LLC | 18,686 | $31.0K |
| Susquehanna International Group, LLP | 13,299 | $22.2K |
| Engineers Gate Manager LP | 13,135 | $21.9K |
| JPMorgan Chase & Co | 10,662 | $17.8K |
Not filed for Q1 2024 yet (1)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| PVG Asset Management Corp | 19,320 | $32.3K |